Keywords: SkyePharma, Kyorin Pharma, Flutiform, NDA, Japan, Bronchial asthma

SkyePharma partner Kyorin files for Flutiform approval in Japan

Article | 26 September 2012

UK drug delivery specialist SkyePharma (LSE: SKP) says that its Japanese development and marketing partner Kyorin Pharmaceutical (TYO: 4569) has submitted ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Skyepharma

Napp Pharmaceuticals

Kyorin Pharmaceuticals

Go to company listing

Related Drugs

Flutiform

Go to drug listing